temoside TEMOZOLOMIDE

Introduction to temoside

Temoside is a medication primarily used in the form of tablets to treat certain aggressive brain tumors. Temoside is effective against glioblastoma multiforme and anaplastic astrocytoma, which are types of cancer affecting the brain.

Composition of temoside

Temoside contains the active ingredient Temozolomide, which belongs to the class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage and preventing their growth and division.

Uses of temoside

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of temoside

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: lowered blood cell counts, increased risk of infection

Precautions of temoside

Temoside can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take temoside

Temoside is typically taken orally as a tablet. The usual starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's advice for the correct dosage and administration.

Conclusion of temoside

Temoside, containing the active ingredient Temozolomide, is a part of the alkylating agents therapeutic class. It is primarily used to treat aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma. Manufactured by leading pharmaceutical companies, temoside is a critical medication in oncology. Always consult your healthcare provider for personalized advice and follow prescribed guidelines for optimal results.